ConductScience.org, home

Paper8913832

Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis.

Stewart DJ and 3 others. Invest New Drugs, 1996. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis. Papers, record 8913832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8913832

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis.
PubMed
Journal
Invest New Drugs
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.06
iCite
Revised in PubMed
2019-10-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stewart DJD J
2Raaphorst GPG P
3Yau JJ
4Beaubien ARA R

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Drug Resistance, NeoplasmMajor topic
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11421389All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.Blood1992https://conductscience.org/library/papers/1421389PubMed
22553992Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.J Natl Cancer Inst1989https://conductscience.org/library/papers/2553992PubMed
31672623Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors.Cancer Res1991https://conductscience.org/library/papers/1672623PubMed
41692761Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.Cancer Res1990https://conductscience.org/library/papers/1692761PubMed
53409465Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung.Carcinogenesis1988https://conductscience.org/library/papers/3409465PubMed
68452330Biological basis for cancer treatment.Ann Intern Med1993https://conductscience.org/library/papers/8452330PubMed
71824825A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1 alpha and etoposide against human melanoma cells.Cancer Res1991https://conductscience.org/library/papers/1824825PubMed
83677093Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.Cancer Res1987https://conductscience.org/library/papers/3677093PubMed
92686531Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.Anticancer Res1989https://conductscience.org/library/papers/2686531PubMed
102538680Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients.J Surg Oncol1989https://conductscience.org/library/papers/2538680PubMed
116346495Clinical pharmacology of hepatic arterial chemotherapy.Semin Oncol1983https://conductscience.org/library/papers/6346495PubMed
128485653Mechanisms by which interferon potentiates chemotherapy.Cancer Invest1993https://conductscience.org/library/papers/8485653PubMed
131704879Chemotherapy for stage IV non-small cell lung cancer.Hematol Oncol Clin North Am1990https://conductscience.org/library/papers/1704879PubMed
148099529Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.Cancer1993https://conductscience.org/library/papers/8099529PubMed
158386368Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8386368PubMed
162539902Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.Cancer Res1989https://conductscience.org/library/papers/2539902PubMed
178094414Cell survival measurements at low doses using an automated image cytometry device.Int J Radiat Biol1993https://conductscience.org/library/papers/8094414PubMed
181292755Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.Oncol Res1992https://conductscience.org/library/papers/1292755PubMed
197306968Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.Cancer Res1981https://conductscience.org/library/papers/7306968PubMed
202545337Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.Cancer Res1989https://conductscience.org/library/papers/2545337PubMed

See all 63 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
41009436Transcriptomic and Cytogenetic Analysis of Oxaliplatin-Resistant Colorectal Adenocarcinoma HCT116 Cells to Identify Markers Associated with Platinum Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41009436PubMed
34431062Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers.Folia Microbiol (Praha)2021https://conductscience.org/library/papers/34431062PubMed
31142791Mechanistic Study of TTF-1 Modulation of Cellular Sensitivity to Cisplatin.Sci Rep2019https://conductscience.org/library/papers/31142791PubMed
29949049Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.Cell Oncol (Dordr)2018https://conductscience.org/library/papers/29949049PubMed
26966512Novel in vitro and mathematical models for the prediction of chemical toxicity.Toxicol Res (Camb)2013https://conductscience.org/library/papers/26966512PubMed
24401732Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.Clin Epigenetics2014https://conductscience.org/library/papers/24401732PubMed
22891266Tissue platinum concentration and tumor response in non-small-cell lung cancer.J Clin Oncol2012https://conductscience.org/library/papers/22891266PubMed
20881640Extensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.J Thorac Oncol2010https://conductscience.org/library/papers/20881640PubMed
20047843Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.Crit Rev Oncol Hematol2010https://conductscience.org/library/papers/20047843PubMed
18204976A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.Med Oncol2008https://conductscience.org/library/papers/18204976PubMed
9547669Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.Invest New Drugs1997https://conductscience.org/library/papers/9547669PubMed
9120546Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas.J Neurooncol1997https://conductscience.org/library/papers/9120546PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8913832

GET https://conductscience.org/api/papers/v1/8913832/references?page=2